The Checkup by Singlecare

DECEMBER 20, 2024

Mixing alcohol with metoprolol can come with various side effects, some of which can be serious. Many people take metoprolol, either as metoprolol tartrate or metoprolol succinate , to help manage high blood pressure and heart conditions. If youre considering drinking alcohol while taking this prescription drug, you should know the possible risks. For some people who know how they react to the medication and alcohol, drinking in moderation may be doable.

Dosage

STAT

DECEMBER 20, 2024

Novo Nordisk’s next-generation obesity candidate led patients to lose a substantial amount of weight in a pivotal study but fell short of expectations, results that cast into doubt the future competitiveness of the company in the booming weight loss market. The treatment, called CagriSema, led patients to lose 20% of their weight at 68 weeks in a late-stage study when looking at all participants, including those who dropped out, Novo said Friday.

The Checkup by Singlecare

DECEMBER 20, 2024

Tizanidine is a generic prescription muscle relaxant available as brand-name Zanaflex, which is approved by the Food and Drug Administration (FDA) for treating spasticity , a condition in which muscles stiffen or tighten, preventing normal fluid movement. Tizanidine is also used off-label (for a non-FDA-approved use) for musculoskeletal pain. In addition, its sedative effects may offer relief to patients with insomnia caused by severe muscle spasms (but this benefit is also not FDA approved).

Dosage

STAT

DECEMBER 20, 2024

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we do foresee a few developments, such as promenading the official mascots, hanging with one of our short people, and escorting Mrs. Pharmalot to a house party or two.

Compounding

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

DECEMBER 20, 2024

With pressure from the House GOP, expected PBM reform was not included in Congress end-of-year spending package.

Packaging

STAT

DECEMBER 20, 2024

The Food and Drug Administration on Friday cleared Eli Lilly’s obesity drug Zepbound as the first treatment for a common sleep disorder in the U.S. Zepbound, whose scientific name is tirzepatide, has now been specifically approved for patients with both obesity and moderate-to-severe obstructive sleep apnea, or OSA, a condition characterized by breathing interruptions during sleep.

Insurance Coverage

PharmaVoice

DECEMBER 20, 2024

The high drama of an election year, industry layoffs, patent cliff strategies and other key trends that shaped pharma in 2024.

Drug Topics

DECEMBER 20, 2024

Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.

FDA

Pharmacy Times

DECEMBER 20, 2024

New mechanisms of action are proving more effective than ever, offering slowed progression.

Drug Topics

DECEMBER 20, 2024

Authors concluded that that the benefit of the vaccine in preventing long COVID is due mainly to the fact it mitigates the risk of infection.

Vaccines

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

DECEMBER 20, 2024

The findings show a need for researchers and health care professionals to consider model designs to minimize disparities when diagnosing perinatal mood and anxiety disorders (PMADs).

Drug Topics

DECEMBER 20, 2024

Although the drug fell short of its 25% expected weight loss, results are still promising for people with overweight or obesity.

Pharmacy Times

DECEMBER 20, 2024

Compounding pharmacies have a 60- to 90-day grace period to complete production as it continues to monitor supply and demand.

Compounding

PharmaVoice

DECEMBER 20, 2024

The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.

Compounding Pharmacies

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

DECEMBER 20, 2024

Vanzacaftor/tezacaftor/deutivacaftor (Alyftek) also received approval for the treatment of cystic fibrosis in people 6 years and older who have at least 1 F508del mutation.

FDA

Fierce Healthcare

DECEMBER 20, 2024

HHS released a list of 64 drugs on Friday that will have reduced co-insurance for patients with Medicare Part B. The discounts come from the Inflation Reduction Act which requires drug makers to give rebates to the federal government when a drug's cost rises more than inflation.

Insurance

Pharmacy Times

DECEMBER 20, 2024

Pharmacists identify appropriate patients for new oral and antibody drug conjugate treatments and provide counseling to help patients navigate the evolving treatment landscape.

Fierce Healthcare

DECEMBER 20, 2024

Smart ring maker Oura pocketed an additional $125 million following a $75 million investment from medical device maker Dexcom last month. | Smart ring maker Oura pocketed an additional $125 million following a $75 million investment from medical device maker Dexcom last month.

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

DECEMBER 20, 2024

Setmelanotide is indicated to reduce excess body weight and maintain weight reduction long-term for patients with syndromic or monogenic obesity due to Bardet-Biedl syndrome.

FDA

Fierce Healthcare

DECEMBER 20, 2024

Ascension's May 8 cyberattack exposed personal information from 5.6 million patients and associates of the system. While it has been suspected since June that hackers obtained the personal information of patients and employees, the system revealed Friday that bank account numbers and addresses were stolen.

Pharmacy Times

DECEMBER 20, 2024

The new approval continues to expand the therapeutic potential of GLP-1 medications such as tirzepatide, now being deemed effective in patients with obstructive sleep apnea.

FDA

Fierce Healthcare

DECEMBER 20, 2024

Epic Systems is asking a district court to throw out Particle Health's antitrust lawsuit, arguing that the startup failed to present the electronic health record company's anticompetitive conduct in its suit.

Pharmacy Times

DECEMBER 20, 2024

The approval follows positive results from the V005 (NCT03005418) clinical trial.

FDA

Fierce Healthcare

DECEMBER 20, 2024

The accreditation evaluated, over 18 months, how well Maven complies with standards across multiple categories. The distinction validates the company's ability to deliver equitable outcomes, executives said.

Pharmacy Times

DECEMBER 20, 2024

The rare genetic disease is a severe hypertriglyceridemia that can lead to potentially life-threatening acute pancreatitis.

FDA

Pharmaceutical Technology

DECEMBER 20, 2024

Novo Nordisk has announced positive results from its Phase III trial of CagriSema but fell short of a previously promised 25% weight loss.

Pharmacy Times

DECEMBER 20, 2024

This could be attributed to improved diet and health awareness.

Pharmaceutical Technology

DECEMBER 20, 2024

The US Food and Drug Administration (FDA) has stood by an earlier decision confirming that the tirzepatide shortage is over.

FDA

Pharmacy Times

DECEMBER 20, 2024

A panelist discusses how the 505(b)(2) regulatory pathway provides a streamlined approval process for modified versions of previously approved drugs, allowing pharmaceutical companies to rely partly on existing safety/efficacy data while still requiring new clinical data, commonly used across various therapeutic areas including reformulations, new dosage forms, and drug combinations.

Dosage

Pharmaceutical Technology

DECEMBER 20, 2024

Astellas Pharma and Sangamo have signed a licence agreement for neurotropic adeno-associated virus (AAV) capsid, STAC-BBB.

Pharmacy Times

DECEMBER 20, 2024

The decision is based off favorable results from the BREAKWATER trial.

Pharmaceutical Technology

DECEMBER 20, 2024

The US FDA has approved Ionis' TRYNGOLZA (olezarsen) as an adjunct to diet for reducing triglyceride levels in the adult population with FCS

FDA

Pharmacy Times

DECEMBER 20, 2024

Compounding pharmacies play a vital role in meeting the unique needs of patients, but pharmacists must adhere to strict safety standards and regulations.

Compounding